-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OM62SSd2vw1BnYmw/P1yVBLy5bdEe2OIuxbAzBd3bYPoT9xAQq7ukP4/ssOB3Zms KQ5y5AEJ+j/F2gnjm4piOg== 0000947871-08-000568.txt : 20081110 0000947871-08-000568.hdr.sgml : 20081110 20081110111409 ACCESSION NUMBER: 0000947871-08-000568 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20081110 DATE AS OF CHANGE: 20081110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MERRILL LYNCH PIERCE FENNER & SMITH INC CENTRAL INDEX KEY: 0000728612 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-89355 FILM NUMBER: 081173986 BUSINESS ADDRESS: STREET 1: 4 WORLD FINANCIAL CENTER STREET 2: NORTH TOWER CITY: NEW YORK STATE: NY ZIP: 10080 BUSINESS PHONE: 2126702273 MAIL ADDRESS: STREET 1: 4 WORLD FINANCIAL CENTER STREET 2: NORTH TOWER CITY: NEW YORK STATE: NY ZIP: 10080 424B3 1 ss50404_424b3-biotech.htm
PROSPECTUS SUPPLEMENT
REGISTRATION NO.  333-89355
(To Prospectus dated August 15, 2007)
Filed Pursuant to Rule 424(b)(3)
 
 
 

 
1,000,000,000 Depositary Receipts
Biotech HOLDRS (SM) Trust
 
This prospectus supplement supplements information contained in the prospectus dated August 15, 2007 relating to the sale of up to 1,000,000,000 depositary receipts by the Biotech HOLDRS (SM) Trust.
 
The share amounts specified in the table in the “Highlights of Biotech HOLDRS” section of the base prospectus shall be replaced with the following:
 
Name of Company
  
Ticker
  
Share
Amounts
  
Primary
Trading
Market
Affymetrix, Inc.
  
AFFX
  
4
  
NASDAQ
Alkermes, Inc.
  
ALKS
  
4
  
NASDAQ
Amgen Inc.
  
AMGN
  
64.48
  
NASDAQ
Applied Biosystems Inc1
  
ABI
  
18
  
NYSE
Biogen IDEC Inc.
  
BIIB
  
26.95
  
NASDAQ
Celera Corporation2
  
CRA
  
4
  
NASDAQ
Enzon Pharmaceuticals, Inc.
  
ENZN
  
3
  
NASDAQ
Genentech, Inc.
  
DNA
  
88
  
NYSE
Genzyme Corporation
  
GENZ
  
14
  
NASDAQ
Gilead Sciences, Inc.
  
GILD
  
64
  
NASDAQ
Human Genome Sciences, Inc.
  
HGSI
  
8
  
NASDAQ
QLT Inc.
  
QLTI
  
5
  
NASDAQ
Sepracor Inc.
  
SEPR
  
6
  
NASDAQ
Shire Limited
  
SHPGY
  
6.8271
  
NASDAQ

The share amounts listed in the table above reflect all previous stock splits, dividends and business combination transactions.


The date of this prospectus supplement is September 30, 2008.
 
 



 
2           The separation of Celera Corporation from Applera Corporation became effective July 1, 2008. As a result, Celera Corporation replaced Applera Corporation - Celera Group as an underlying security of the Biotech HOLDRS Trust. For the 4 shares of Applera Corporation - Celera Group per 100 shares round lot of Biotech HOLDRS, The Bank of New York received 4 shares of Celera Corporation.
 
 
GRAPHIC 2 biotech.jpg GRAPHIC begin 644 biotech.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``("`@("`@("`@("`@("`@,"`@(" M`P,#`P,#`P,$`P,#`P,#!`0$!`4$!`0%!08&!04'!P<'!P<'!P<'!P<'!P?_ MVP!#`0("`@,#`P4$!`4'!@4&!P@("`@("`@'!P<'!P<'!P<'!P<'!P<'!P<' M!P<'!P<'!P<'!P<'!P<'!P<'!P<'!P?_P``1"`!8`4P#`1$``A$!`Q$!_\0` M'0`!``,!`0$!`0$```````````8'"`4)`P(!!/_$`$@0```%`P(#!`,*#`0' M``````$"`P0%``81!Q(3%"$(%2(Q&$%A%A5GI:,A(MJ!!X\@T$D]_(;\MU\IZB*%A?(X,:.9<0`.[F=N:A7OR:0_I5TW_\FA?Z MJI'[@8GYK-_EO_\`E1WW?PSSJ'_,9_\`2E4#=%N74V4>VQ/0MQ,4G!VBC^"? MM)!N5=,B2AT3*M%5``Y2K$$2CU`!`1Z&+GPU-'/3.TS1N8ZU[.!:;>6QMMLO M=35<%0W5#(U[;VNTAPOY+B^^Z[8'R&2@)@R&T0$N#`./$'7RZUYUZ%^Z(E$2 MB)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41 M*(E$2B)1$HB41*(JEDO?:N>7>QT7W;IC:C"2,V]TCCDYVYIA%!9BKQXF/^%B M8I!RGSB)57PNU\;#F9(F\IR'[F4\0>^]1*1XF\<3"0[9[MI)".R;,T-YCB.4 M'-]TZB4L9:GB!\?:25X!;NQN\<8/:%WZW)8'C&JYMYC.&K$2&014,*RPB8A`'<Y&P^8>12CL,HW0B$PQF-IN&Z&Z0=]PVU@=S\Y\J\ M_=:+;CNS'K#8&H]COY*#A;NDGAKDMF&22!`K!DYCU)=FR255X1V[U)T`IME< M%063`Z1R%!$$-2R]52Y@PJHHZD!\D0&A[KWU$/T%Q&]VEN[ANYILX'M:LNS# M2Q9?Q6GK*8ED:[I>N6?&X0,.' MQ>743W[-YL9\LCCSKF?V16/8GAOW,ZE530:^L:N%(^/5IZOIU:"+VN;7Y7/E M6R=$N%T58*WK$,VKE>PO\0\EQ;&A\C(2VE]LR$J^>2;]<9+ MCO9!=1PNILEW:9-ZRICG-M(4"AD>@``>K%:9T.U]36Y0H9ZF5\LKN+=[W%[S M:HE`NYUR;``"_<`%3>D"EAI\?J8X6-8P:+-:`UHO$PFP&PWW^-6Q6F*FK/?: M3FIB"L:*=PDM)0SI2ZV[=1U%NEFBIDACGYS)F40.F82B8A1QG&0`?5D,-Z?\ M6KL.R]!+1SR02&K8TNC>Z-Q:8ISI)80;7`-N5P%I71;0TU7BLK*B)DC1`XV> MT.%]<>]G;7L3NI9H?(R$MI?;,A*OGDF_7&2X[V074<+J;)=VF3>LJ8YS;2%` MH9'H``'JQ5FZ':^IK@A'N;CNZXW)XVR[+C3 MD*^F7Q2;S@!S^!JT:D^%>/%?@FR7B-DPD(>3PS#'5;G$N#(6"\DA\5C?^3G< MF,&[SL.\B,Q/$VTC6@-+YGFT<8\9[O\`BUO-[SLP;GN!EL-WOW1%>Z#NWO\` M[M;=]]S<;D.?X)>$WBVXEAJTWTZK;Z;[VOROO9=*ODOJE$2B+S9[5_P!U(=&G8[;>,%DNK<;[^*5MFXW3AG9%^.FCE1HZ;6C*.FR[ M,$'<$%[000=B".:SCV;;KNB=OF6:3=RS\PU3M1RX3:RL@[=I%5+(LB%5*FNJ M6#+V M)2Q.+)&4D[FN:2'-<(7D.:1N"#N"-P5,9>B9)BM(QX#FNGC!!W!!>T$$'8@C MFL,:>,=8=3.^.X=1YEIW)RO-=[7!-I[NLJ9(F_\`E$KZFGW#6]MLH<&[R:6\>)MW[QZBT.5D MPJ3)V/1F**GA:\^X+&PR[:CV2P@G9MW<-YLWQ[`V&K])-46>ID(LN+?D9Z(X M*$\Q3`PH`=;?P7+50V=,HR8%5AH=K@DN8W;:K-YM>![IMQO;2Z MX(L=3&VQ6F*FJ)7ZY<,[%O1VT76:NFMIR[ELZ;G,DJBJG'K'3524()3$,0P` M("`@(#U`:K.=)Y8,O8E+$XLD923N:YI(0YI&X(.X(W!4QEZ)DF*TC'@ M.:Z>,$'<$%[000=B".:PQIXQUAU,[X[AU'F6GHRS M@?"ZQA\;N+JMHAB/B6O>[F^^%OB/+NLSWG.T%^E/^);E]OZO[:T+P5=)GY=_ M?*OU2JG\M\F_DS]W@]/YS[?-:L]16.L.F?='?NH\R[[ZYOE>Z;@FU-G)\(5. M+S'+XSS!=NW/D.<=*SW/='GG*?5^NXQ,_CZ]/"JJEUN'P]6K6&>_%K7[[^FU MY:J,LX[QNKX?&WA:;ZX8AX^NUK.=[TWY=W]W;FFMRGN^Q+9N!8RRCI[&E2D% M5R(I&5>M#F9/5@30^#*51PBH0P+-6%##L7J:9M@UKSI`)-F.[;!<[W#7`&]][[ MGFIQ5Q5?65>T]=5QV\VLUM`SDE"IR"THN]-%KG:JJF:$:E0`RZ)B*[2@X4\` M'VB(@)@$2E$O-GLB,R8KAD>&QT53)`)3,7\-Q8YQCX(9=[;.L.([LWTDD$@E MK;;!T38/0UCJQ]3"R4L$8;K`IV'BIMIJ@L MFUF(UM*M4W%QW&54J3M$%TRJE(B8H&`IPR`&$,^0^55/".CSI'Q&AIZR+'"( MYXV2-#JNKU!LC0\!UHR+V.]B1?O*G<0S7E"DJ9:=^&C5&]S#:GAM=I#T_G/M\ MUIQI]8&M5L3YWT[?,9-QCB-=L54).1GI8$%3DXC1TBS<`U3,8C@B8'^%((I" MJ4IBF,`A<OH^'343XI`]K@6QPQ7`)U-+VEY`+2;=D]L-)!`LO\`%`:6ZRMF M:[:4U160=FGXN4:RB$A+2QD&[%K)@NW%H^!NFL5PX7:;TCFX9RD$3YV$(;R8 M'T<9[BIW1U..%KS402-D$L]06LBCJ-;.'*(VO$DCX-4;CH%(PL,<<5W/=%I=J8YQ!8QLEG`:@2`VVJ[;KT_A[@@+1B8FZ97O MJ>:T*Y1]D]_1/\`B?\`K+7-V&UK M'<&\[F7*N6JS$I9JNNX4[K:F<:%MK,`'9>"X7:&G<]_<#M,_?A[0?Z+/X:N/ MV_K?T?WY6SPK=)?Y"_DC.N;\8PR.#&,- MZK`)FN#^!/%>0,>`W5,YS3=KGG2!?L^0&]KRAES`,/K'RT%9QI3&6EO%B?9F MH$NM'I/,-WY;^4[:P[/_`,D=I_3*_;3VNF>@_P!I.'_IO]S,L;Z2?;'5_H_J M8UV]6=3(;22R):\I=,'@LP(WBXVEE@&MW"\V"8?,P& MIJ[&KD':[PQM[MB9[UK?=6OJ?E$2B*&:C?)[ M??[&S7V:O54SY[6L4^1U'U+U.99_'%%\HB^L:LU=DKSU`_V/^(T,]'*2&3QOC<6VU!LC2PEMP1>QVN" M+]Q7JH*Q])4Q3LL71O:\7Y7:0X7L0;;=Q'QK#W96&ZDE=JKG- M0S4;Y/;[_8V:^S5ZJF?/:UBGR.H^I>IS+/XXHOE$7UC5A[0_52WM,_=1W\TF M7??7=W*]TIME=G)\[Q>+S+E#&>.7;MSY#G&*XZZ'.DC#,I]=Z[',_K'!T\)K M'6X?%OJUOC^$%K7[^6U^@>D+*%9CO5^KOC;PN)?62/&TVM8/]X;\N[^[?OI4 M:??,]X_58SV_YC[*V[[Y'+/F]9_EQ?Q"S?P08S\+3_3?Z?S7H^VZSYKAJM#Z MF+VZ6$CY)DU@T7IE%I7@)JJJO12`2%1;JJE`J96Q1W"IDPF$-I=F389TP])5 M#FR6C%'#(R.G$ES)I#G.E,>P:TO`#1&.UKNXN(TC2"[2\@9/J<"94=8D8YTI M;LRY`#`_>YT&Y+CM;:W/*A&D7::C6&C6T6V4PWL`+\@ MKKB'19A-74RU#Y9PZ1[GFSH[7<7.-KLO:_E/_P"VZ?I4:@]?^$6;]4D?;_F7 ML_OU2'WR69O-J/Z$W\0O(>B#!OAJCZ4?I_-^C[=UHZ2:_P`Q>MUI6MT*Y1]D]_1/^)_ZRW+H8Y5_Z'_2?TC[?.KD[/\`\D=I_3*_;3VM7Z#_`&DX M?^F_W,RHW23[8ZO]']3&KDK5U1EFCM4?)]#_`+8M?LR1]H5S[[)+VLT_RR/Z MFH6J]$'XYE^3O_\`>+TC[?.IGV?_`)([3^F5^VGM6OH/]I.'_IO]S,H/I)]L M=7^C^IC63]0KR:Z@=K>T[9=#&OK6TG*Y6;IDD6I04FRQ_>*[I-1,4%S+-9$C M)NHT!1;8+-0YR`07!`ZFI*0X=E6><7$M38>*?$+M(!Y@!S"\A]FWX@`-]"YW MJZL8CFJ"`V,5-<^,/'#=1(Y$EKPP%EW6X9)%M:W+;`"[1!\08_*$?\`"B+]419`UM[75I:; M*O[;M)%"\;V9NW,9(-Q.LC&0[A)OT.\<%)^&'(X.4AFS8X#X%B*K-U"E`][R M[D6IKP)9[Q0$`CWSQ?W(]R+TAK@=J)F+/--0$Q06EG!(/O6&WNC[HWY MM:>YP+FD+%^E&EERZY72[U)U*=2,A"/9$SEXY<&,DZN!VF/#Y1J*6S@,T-@( MG,@!`(4O+-M@E$S>ZYDS)3X)3BBH@!*!8`;B('W1\KSS`-[WUOOJJF46.GGIO)C(]/7Y`' M0`QZQZCD1'#UN"YFHH8T^OT>O6SIH>HC\V+!TZ]*JF?/:UBGR.H^I>IS+/XX MHOE$7UC5A/0*\;2[L8+VTX8)+BBY<97.^:+%)L:D6.&2(G'(E`. MGGY!7%_0CFG"\`QR:IQ&7A1.IG,!TO?VS+`X"T;''DUV]K;<]Q?HGI(P6MQ3 M#60TC-;Q,'$:FM[(;*";O'#)7G_`.PJ M/4K$_!MF/S7]K#ZQ/2`TB_.X/W9,_P!'3PX9*\__`&%1ZE/!MF/S7]K#ZQ7) M6KJC*&:C?)[??[&S7V:O54SY[6L4^1U'U+U.99_'%%\HB^L:L;]GC4"T;%]V M'NJE^Z^].Z^1RV>.>)RPO^/_`,HDMMV\4GQL9ST\AQRAT$9WP3+OW0^Z4_!X MW`T=B1^K1QM7\VQUK:V\[7OM?=;GTG9;Q'%NJ]4CXG#XNKM,;;5HMX[Q[T\O M)OY%I?T@-(OSN#]V3/\`1UT'X<,E>?\`["H]2LI\&V8_-?VL/K%6>IG:.MP( M-_#V(N\DI639&;!.`FX8MX\BY54UE$3*BW=BZ2`H"GM(4A1,4_$$2&3'/ND' MI\PO[GRTN"N?+/*S3QM+XF0AVIKBW5HE,S18LLT,!<'ZW%AC=:LJ]%U;UILV M(AK(HS?AW:]TA;N`;%S.&3<.N=1L6Z1?6.;V6;-<(DFK[=@LDD\2/;T.F.XI M5DBK$7?.1`Z>#E!5))),Z:F-Q5RF+D`Q'>QNRG)&VIQJ6[0\<"(<@YMVOE?N MS<:FL8QS7D:FS-<+@%>SI?QUCS%AS+$M/$?WZ3VFL;XQL=+G.<"V]C&0;&RV M%75*Q!0S4;Y/;[_8V:^S5ZJF?/:UBGR.H^I>IS+/XXHOE$7UC5E'LPV[;\^- M\=^P<--S-L\X/%&1XG"Y@JFS?L+G&,X#/ETYF]CK@&&8E]T^NTL,^ MCJ^GBQLDTZN/JTZVFU["]N=AY%LO2WBM;1FCZO/)%JXM]#W,O8QVOI=O:YM_ M;\0M'5K06'N6+[QLF,C8*XXU$P)1[!)%DRDT@W&Y=0B?#227R(\-8<`/XM4= MNQ1'1^DWH4H<5I./A$$5/61#9C&MBBG;ST$`!K9/>2;`^)*=.E\50R;TCU5# M/PZ^1\M.\^,XN>^,\M0N;EGOF?WF=JX?GS2O42WK)D$(*^K*AEN0F?!<:\8V M+-0BR:J@JL,P"I918SAD+N'-M.8& M=:I7`[Z_P7$DT26/,31=K3Q+1QC3,X9:K,4A=48?6R#7'_-"4\&8'WOX32W4 MRXY&-^U]%WN7H:W<-WC=!VT71=-72)'#9RW.51)5)0H'3524((E.4Y1`0$!P M(=0KNN">*>)LL3@^-X#FN:06N:1<.:1L01N"-B%S)+$^-[F/!:YIL0=B"-B" M#N"#S"^U?5?A0"ZM4+%LF01BKGG0C'Z[(L@DAR;]QEN=11(JF]JW5(&3HG#` MCGIY8Q5)S)TBY>P"I;38C4\*5S`\#ARO[!]IY$>A1KT@-(OSN#]V3/]'5>\.&2O/_V%1ZE2W@VS M'YK^UA]8GI`:1?G<'[LF?Z.GAPR5Y_\`L*CU*>#;,?FO[6'UBH*`N"(NGM1, MYV"><]%/N)RKKAK([^#::C=7X)P5-0,*)F+U)ZLAD.M8E@>-T6,=+T=;12<2 M"35I=I'5&'Y"=35#=,K+7%P;7J]0W:XCD1Y M?U;;AKL1<_)1$HB41*(E$2B)1$HBK3432RW]3.Y^_7DRT[EYKE>Z%FZ6[G.# MQ.+QVZ^<<`NW&/7Y],9]GOHVPS-G5^NR3,ZOKT\(L%^)HOJUQR?!BUK=][JU MY8SA68%Q>KLC=Q=-]8SWYO>_52:K"HI0>_[`A]1H=M"3 M;F3:M6LDG*IJ12B*2HJIH+-P*8RZ*Q=NUV_EL&6\R5."5+JBG:QSG,+.WJ(L2T^Y.LNW(ZVHE=XYCX[CBW7?G347-S+E1V?>=%-(@^-4<8('3'TU(95RW38! MA<.'4SGNBBU6+R"_MO=(;EK6CFXVLT;6^->3',8FQ2MDJY@T/DM<-OI[+0W: MY<>0\J\/;SN22=IO&I7!TFYUT3%442 MXG#2,8H[@!,WQ>LZ;#J>MP6&G?**Z.%3-_"ET3K#FTN%^_26:K@>5P;?;;G;^7'V[]-(]*3 M3MJVKMN-^UUW.;MRM8-)OL;/MW@GO\`)5])5`P.X,TYJQJVX5@VCI:W+>DEC,&UI6IQ@5>IN#.&Z;9^\)^%OS+(.00 M52#8W6$I3*X![VBYD?:S;6)*P`MU`[N;OV[*@XOF_$\ M4=PFDL8XV$;+W=>X`)\9Y(.DC9KMNQ=3_1OLR/WSN.G;R;$<"FY.9.U?@E4O M`8`07?+E4%)D$/:Z"@O8C^=W!](8T@$=PUFQ&^ MD>*]6W+71\6.;/7VN"?P6Q'H+W`D$F0#XH`/01''4/[\Q_"_:Y\U%-YV'EH M1V=9-I,1CJ*CE)#)XW MQN+;:@V1I82VX(O8[7!%^XKU4%8^DJ8IV6+HWM>+\KM(<+V(-MNXCXUGST6- M/OGB\OKD=]WUAGWMN6?.*SZBQI]\\7E]N3T6-/OGB\OKD=]WT^]MRSYQ6?3A_AT\,., M_!4_T9/7+2U=!K*%S)J*;SL/+0CLZR;28C'44Y4;"4JI4G:!D%#)&.4Q0,!3 MC@1*(9]0U'XMAL>(T,]'*2&3QOC<6VU!LC2PEMP1>QVN"+]Q7JH*Q])4Q3LL M71O:\7Y7:0X7L0;;=Q'QK/GHL:??/%Y?7([[OK#/O;N3T6-/OGB\OKD=]WT^]MRSYQ6?3A_AT\,.,_!4_P!&3UR[\!V<]-(- MQS2[23N%0JR*[1P50H@`!C&X!F\$Z!,IX?) MQ'QR51NTMX[P6M+3?Q(VQ->';:FRB1I`M:Q=JC<2Z4<=JV:6O9"+$'A@@G5Z M7N>6D;Z2PM(OZ&VO%NW;LVZ#1H@BU:M42-VS9N0J:22290(FDDF0`*0I"@`` M`!@`Z!6QP0101-BB:&1L`:UK0`UK0+!K0-@`-@!L`L]EE?(]SWDN=AY:$=G63:3$8ZBG*C82E5*D[0,@H9(QRF*!@*<< M")1#/J&H_%L-CQ&AGHY20R>-\;BVVH-D:6$MN"+V.UP1?N*]5!6/I*F*=EBZ M-[7B_*[2'"]B#;;N(^-0?3S2RW]-.^.XGDR[[ZY7FN]UFZNWE./P^%P&Z&,\ MP;.<^K&*IV1.C;#,I]8ZE),_CZ-7%+#;AZ].G1''[\WO?NY;WL.9\X5F.\+K M#(V\+5;0'#Q]-[ZGN]Z+6M_HK+K055%4-]Z)V7J!)I3,IWG&R94>`Z=P:J"! MGA2@!41=@N@N4YDBAM*<``VW!3"8I$P)EN=.B#`(H%,8 MXFL.2\EP99I'4E-4U$L%[M;,YCA&3?5P]$;"`\[N:26ZKN:`YSRZ*S%F*7&9 MQ/-#$R2UB8PX:_)KU/=M'\?DB,K M$*)(NS(#N$6JIU4EB*);S;R@8F2&SL$N\^[/L\=&>"YJX3JP/9+'L)(BULFC M?\&XN8\.9^&ES2'6V-C8BUP= M+=-:>BQI]\\7E]BQI]\\7E]< MCON^GWMN6?.*SZZX:=P!87L2"6M MTV]6I*DI1$HB41*(E$2B)1$HB41*(E$2B+^!G`9$!''40#`9]@=:(O/O7SLA MREZ7/(7U84A',I">JCUKG MD:FN%FWMNX%H.YV)!;N2YVKN6-%.SIJTW>.FCJVE&P-C&*5T*@+(K"!@`O"! MKQ5<'*.\!.0O3SP;!1N$O2%@[(FO#GN)MV0WM-V[]6EFW(Z7'?E<;JGQ='N+ MOE"9%@C@PE,7` M'%R[V%3VG'(@*1O"'F&0$(#$>DYMK4D!O;QI-K&^_8:3<6[]8W[MMY_#^C)U M[UU//4"_]6=XOC]=B3KSR$MOLT;,'.UF^47(U&[K;%Q6B81@% M#AK;01@.MNX[O/*]W>0V!TBS;[AH6G8B`C(M-+E4-IDB@4BX'$=X>>\!`?R_ M6'E]/F,,IE=P@&#.XP&$1`>F0#XH`/01''4/[\Q(OW1$HB41*(E$2B)1$HB4 M1*(E$2B)1$HB410#5=F\D=+=2H^/:N7S]]8%PLV+%FD=9PX<+1#A-%!!%,!. MH=0X@4I2@(B(X#K4G@DC68C3.<0&B6,DG8`!XN2>X*,QN-S\.J6M!+C%(`!N M22PV`'>5Y4VUI+J6PL;59M&VAJB9A+V!;Z4A$3-NNXH[BXBWA$NBH1L85PZ6 ME2,F:+TY78)$,F0RG$20!0.)ME7CF'OK*0OF@U-EDLYL@?:/@R"[G6:(]3BS ML7-R!8NMMBE)@=>RCJPR&?2Z*.[71EEY.-&;-;=QD#6A_;L+`FX;?>_M<[+- M(ZCZQ/;NTGU1U!6FK2B&VC$[:C63DHR%<)0KA!SS/(/4DT"!+B"PH*(J#^,5 MX6U8!6J^6\0T4%&V"K@@#9'=8:\M:YXU@BVIIN>'MJ!'<-79[-GS)A^NOK'3 MTD\Y=&WJ[F!SFL.@@WTN%AQ-])![SI[7:G\-V7K$?2^GAKVL>2?RTOIO*R^I M:\/-P?:Y)DY&SM MSO;;,NAVE-QPSZ5>J67K&PU$?6!=L7:*[NV'4##0L\YB'B<>_"Z5I1`0.J@! MFZ?&9IE*NX+@P"F16K?F/&X)6-;QJ8TXEB+[2"1[XP]NIO"##L#VC9Y):WEN M0J?ES!)XGN=P:D5!BE#+QF-C)"QVEW%+QN1V1=@`<[GL"K`M#3)LK:;]S9^C MVK5DW1#Z)W/#7Y)3ZTA%M+EEI.V#,D6,?`NBR#B:X\B51PFD@+%-`Q4SG!13 MET*C*_&'"I:)ZRGEB=4QNB#=+C$QLMRYT@T".S+-)/$+MP+#4Y2E#@[33.,% M'412MII&REVI@E>Z*P:V,ZS)=]W`#AANQ-SI:I_8>GNJL-?798D[IFYNZ(.- MM*;($6>UTXHED$5L]%!.+E'S8!.H=0YDVI3/=AQ.@.`WF,`1>)XKALM'BK(6 M-C>Z1F_$U\?\,3K8T\@-W=BXL[R`*3PS"\2BK,*?,]TC&QOVX>C@?@0-+G#F M3LWMV-V^4E;SK,UIB41*(E$2B)1$HB41*(E$2B)1$HB41?,X=2^%0?:4V`#Q M%\PW!G_'Z,AZ\"1?,JH;N$!%-Q2AD#"41#XOF.XG\\'(OMO`3\(0.`XW@.<`(`(>6!R/7S_]]!#)%]`# M``'7H&.HB(_ZB/4:(O[1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$ MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$ M2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB4 M1*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B) 61$HB41*(E$2B)1$HB41*(E$2B+__V3\_ ` end -----END PRIVACY-ENHANCED MESSAGE-----